Stock Report

Download full stock data and analysis for free Last Updated: 03-Nov-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Amerise Bioscience Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

BSE: 531681

₹0.84

up-down-arrow ₹0.02 (2.44%)

As on 02-Nov-2026IST

Market cap

info icon

₹6 Cr

Revenue (TTM)

info icon

₹0 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

1.1

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- -68.65 -- -52.19
EBIT 29.63 48.18 -296.43 11.24 -182.08
Net Profit 29.63 -35.71 -265.00 17.67 -173.20
EPS 30.08 -34.38 -266.67 17.68 -173.19
Book Value -- -- 0.11 -1.56 -0.17
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-25Mar-24
EBIT-Margin info ---0.22-140.51----
Net Margin info --5.73-53.23----
Return on equity info -1.57-0.18-1.240.11-2.68
Return on Assets info -1.30-0.69-0.870.08-2.65

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Amerise Bioscience
--
0.15
-2.65
-2.10
10.17
Peer Median
--
11.60
10.11
13.59
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

-1.24

Lower than Peers by 9.25

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Amerise Bioscience
-1.24
0.11
-2.68
-2.13
10.24
Peer Median
8.01
12.49
10.06
11.95
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-0.87

Lower than Peers by 3.14

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Amerise Bioscience
-0.87
0.08
-2.65
-1.35
6.24
Peer Median
2.28
2.73
6.32
8.16
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-140.51

Lower than Peers by 225.19

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Amerise Bioscience
-140.51
--
--
--
-0.22
Peer Median
84.69
60.33
81.42
64.52
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-53.23

Lower than Peers by 116.41

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Amerise Bioscience
-53.23
3.03
-406.96
-1,351.14
5.73
Peer Median
63.19
55.47
586.12
83.76
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Amerise Bioscience
--
--
--
--
6.10
Peer Median
0.00
--
0.00
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-68.65

Lower than Peers by 88.90

Year on year growth in net sales

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Amerise Bioscience
-68.65
--
--
-100.00
--
Peer Median
20.25
18.65
37.98
8.59
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-296.43

Lower than Peers by 313.60

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Amerise Bioscience
-296.43
0.83
-42.40
-544.44
94.12
Peer Median
17.17
18.77
64.67
-5.20
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-265.00

Lower than Peers by 275.96

Year on year growth in profit after tax

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Amerise Bioscience
-265.00
103.90
-22.88
-121.65
262.91
Peer Median
10.96
-1.74
63.83
2.11
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

-266.67

Lower than Peers by 276.01

Year on year growth in earnings per share

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Amerise Bioscience
-266.67
104.07
-22.78
-121.66
262.94
Peer Median
9.34
0.48
42.57
4.66
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Amerise Bioscience
--
0.11
-2.65
-2.11
10.79
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Amerise Bioscience
--
--
--
0.02
0.01
Peer Median
--
0.02
0.02
0.03
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

0.03

Lower than Peers by 13.94

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Amerise Bioscience
0.03
0.01
1.48
0.37
0.99
Peer Median
13.97
2.29
2.69
3.06
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

0.03

Lower than Peers by 13.22

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Amerise Bioscience
0.03
0.01
1.48
0.37
0.99
Peer Median
13.24
3.92
25.81
21.06
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Amerise Bioscience
--
39.00
-486.00
-1,188.00
1,374.00
Peer Median
417.42
16.47
177.44
210.87
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

-84.09

Lower than Peers by 109.90

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Amerise Bioscience
-84.09
1,011.11
--
--
16.37
Peer Median
25.81
17.90
14.11
6.91
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

1.05

Lower than Peers by 0.48

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Amerise Bioscience
1.05
1.12
0.81
0.84
1.59
Peer Median
1.54
1.31
0.47
0.37
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Amerise Bioscience
--
--
--
--
--
Peer Median
0.09
--
0.29
0.45
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

-84.16

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Amerise Bioscience
-84.16
767.96
-29.76
-39.57
16.48
Peer Median
--
28.31
39.08
15.85
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

6

Lower than Peers by 1,421

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Amerise Bioscience
6
--
--
--
9
Peer Median
1,426
1,801
858
471
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...

Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds